These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 15059069

  • 1. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [Abstract] [Full Text] [Related]

  • 2. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DP.
    Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of low-dose amphotericin B lipid complex for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies.
    Subirà M, Martino R, Sureda A, Altés A, Briones J, Brunet S, Sierra J.
    Methods Find Exp Clin Pharmacol; 2001 Nov; 23(9):505-10. PubMed ID: 11876025
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
    Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RH, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS.
    Clin Infect Dis; 1996 Feb; 22(2):315-21. PubMed ID: 8838189
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
    Mehta J, Kelsey S, Chu P, Powles R, Hazel D, Riley U, Evans C, Newland A, Treleaven J, Singhal S.
    Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254
    [Abstract] [Full Text] [Related]

  • 9. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II, Hanna HA, Boktour M, Jiang Y, Torres HA, Afif C, Kontoyiannis DP, Hachem RY.
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [Abstract] [Full Text] [Related]

  • 10. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II.
    Cancer; 2008 Mar 15; 112(6):1282-7. PubMed ID: 18224662
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR.
    Bone Marrow Transplant; 1997 Feb 15; 19(4):343-7. PubMed ID: 9051244
    [Abstract] [Full Text] [Related]

  • 12. Renal effects of amphotericin B lipid complex.
    Luke RG, Boyle JA.
    Am J Kidney Dis; 1998 May 15; 31(5):780-5. PubMed ID: 9590187
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM, Seibel NL, Walsh TJ.
    Pediatr Infect Dis J; 2005 Feb 15; 24(2):167-74. PubMed ID: 15702047
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature.
    Martino R.
    Curr Med Res Opin; 2004 Apr 15; 20(4):485-504. PubMed ID: 15119986
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA, Adler-Moore JP, Schwartz J, Jensen GM, Proffitt RT.
    Antimicrob Agents Chemother; 2006 Jun 15; 50(6):2122-31. PubMed ID: 16723574
    [Abstract] [Full Text] [Related]

  • 16. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
    Drew RH, Dodds Ashley E, Benjamin DK, Duane Davis R, Palmer SM, Perfect JR.
    Transplantation; 2004 Jan 27; 77(2):232-7. PubMed ID: 14742987
    [Abstract] [Full Text] [Related]

  • 17. Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
    Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, Hiemenz J, Chanock SJ.
    Pediatr Infect Dis J; 1999 Aug 27; 18(8):702-8. PubMed ID: 10462340
    [Abstract] [Full Text] [Related]

  • 18. Amphotericin B lipid complex.
    Rapp RP, Gubbins PO, Evans ME.
    Ann Pharmacother; 1997 Oct 27; 31(10):1174-86. PubMed ID: 9337444
    [Abstract] [Full Text] [Related]

  • 19. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
    Cagnoni PJ.
    J Antimicrob Chemother; 2002 Feb 27; 49 Suppl 1():81-6. PubMed ID: 11801587
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.
    Schuler U, Bammer S, Aulitzky WE, Binder C, Böhme A, Egerer G, Sandherr M, Schwerdtfeger R, Silling G, Wandt H, Glasmacher A, Ehninger G.
    Onkologie; 2007 Apr 27; 30(4):185-91. PubMed ID: 17396041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.